PraevoSkin Emulsion in the Prevention of Radiation Induced Dermatitis

NCT00840515 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2009-05-06

No results posted yet for this study

Summary

A phase 2 double blind randomised study of PraevoSkin,a melatonin containing emulsion, in the prevention of radiation induced dermatitis.

Conditions

  • Prevention of Radiation Induced Dermatitis.

Sponsors & Collaborators

  • Pharm Olam Pharmaceuticals Ltd.

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2009-06-30
Completion
2009-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00840515 on ClinicalTrials.gov